Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.

Hypertension, heart failure, and chronic kidney disease represent a significant and growing global health issue. Current therapeutic strategies for these conditions are mainly based on lifestyle interventions and pharmacological approaches, but the rates of control of blood pressure and the therapeutic efforts to prevent progression of heart failure, chronic kidney disease, and their sequelae remain unsatisfactory, and additional options are required. The contribution of renal sympathetic nerve activity to the development and progression of these disease states has been convincingly demonstrated in both preclinical and human experiments. Preclinical experiments in models of hypertension, myocardial infarction, heart failure, chronic kidney disease, and diabetic nephropathy have successfully used renal denervation as both an experimental tool and a therapeutic strategy.1–6 In the absence of appropriate drugs to pharmacologically reduce blood pressure in severely hypertensive patients, therapeutic splanchnicectomy and even radical surgical sympathectomy were used since the 1930s. In patients with end stage renal disease (ESRD) and uncontrollable hypertension, an even more radical approach, such as bilateral nephrectomy, is sometimes considered. Surgical renal denervation has been shown to be an effective means of reducing sympathetic outflow to the kidneys, increasing urine output (natriuresis and diuresis), and reducing renin release, without adversely affecting other functions of the kidney, such as glomerular filtration rate and renal blood flow. The human transplant experience has clearly demonstrated that the denervated kidney reliably supports electrolyte and volume homeostasis in free-living humans. On the basis of these findings and in view of the demand for alternative treatment options, targeting the renal sympathetic nerves as a major player in the pathophysiology of hypertension, kidney disease, and heart failure is a very attractive therapeutic approach. ### Role of Renal Sympathetic Nerves in Cardiovascular and Kidney Disease The renal sympathetic nervous system has been identified as a major contributor to the complex pathophysiology of hypertension, states of volume overload (such as heart failure), …

[1]  G. Dibona,et al.  Neural control of renal function. , 2011, Comprehensive Physiology.

[2]  H. Krum,et al.  Renal sympathetic-nerve ablation for uncontrolled hypertension. , 2009, The New England journal of medicine.

[3]  M. Esler,et al.  Sympathetic activation in chronic renal failure. , 2009, Journal of the American Society of Nephrology : JASN.

[4]  Krzysztof Bartus,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2009, The Lancet.

[5]  M. Sivananthan,et al.  Relationship Between Central Sympathetic Drive and Magnetic Resonance Imaging–Determined Left Ventricular Mass in Essential Hypertension , 2007, Circulation.

[6]  R. Marcus,et al.  Regression of left ventricular hypertrophy after bilateral nephrectomy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  F. Schaefer,et al.  Impaired autofeedback regulation of hypothalamic norepinephrine release in experimental uremia. , 2005, Journal of the American Society of Nephrology : JASN.

[8]  G. Eisenhofer,et al.  Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. , 2005, European heart journal.

[9]  T. Dwyer,et al.  Renal Denervation Abolishes Hypertension in Low-Birth-Weight Offspring From Pregnant Rats With Reduced Uterine Perfusion , 2005, Hypertension.

[10]  H. Ehmke,et al.  Sympathetic modulation of renal hemodynamics, renin release and sodium excretion , 1989, Klinische Wochenschrift.

[11]  B. Massie,et al.  The clinical challenge of cardiorenal syndrome. , 2004, Circulation.

[12]  J. Joles,et al.  Causes and Consequences of Increased Sympathetic Activity in Renal Disease , 2004, Hypertension.

[13]  P. Blankestijn,et al.  J Am Soc Nephrol 15: 524–537, 2004 Sympathetic Hyperactivity in Chronic Renal Failure: A Wakeup , 2022 .

[14]  G. Luippold,et al.  Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  M. Esler,et al.  Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation , 2004, Hypertension.

[16]  G. Dibona The sympathetic nervous system and hypertension: recent developments. , 2004, Hypertension.

[17]  V. Oberhauser,et al.  Moxonidine treatment of hypertensive patients with advanced renal failure , 2003, Journal of hypertension.

[18]  V. Campese A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications , 2003, Journal of Clinical and Experimental Nephrology.

[19]  M. Esler,et al.  Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy , 2003, Circulation.

[20]  G. Dibona Neural control of the kidney: past, present, and future. , 2003, Hypertension.

[21]  M. Esler,et al.  Regional Sympathetic Effects of Low-Dose Clonidine in Heart Failure , 2003, Hypertension.

[22]  K. Rahn,et al.  Sympathetic Nerve Activity in End-Stage Renal Disease , 2002, Circulation.

[23]  V. Campese,et al.  Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. , 2002, American journal of hypertension.

[24]  C. Zoccali,et al.  Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease , 2002, Circulation.

[25]  G. Dibona Sympathetic nervous system and the kidney in hypertension , 2002, Current opinion in nephrology and hypertension.

[26]  T. Nozawa,et al.  Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats , 2002, Heart and Vessels.

[27]  W. Grzeszczak,et al.  Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? , 2001, Journal of the American Society of Nephrology : JASN.

[28]  V. Campese,et al.  Neurogenic factors and hypertension in renal disease. , 2000, Kidney international. Supplement.

[29]  P. Blankestijn,et al.  Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. , 1999, The New England journal of medicine.

[30]  M. Koss,et al.  A limited renal injury may cause a permanent form of neurogenic hypertension. , 1998, American journal of hypertension.

[31]  V. Campese Neurogenic factors and hypertension in chronic renal failure. , 1997, Journal of nephrology.

[32]  M. Koss,et al.  Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  J. Granger,et al.  Renal denervation attenuates the sodium retention and hypertension associated with obesity. , 1995, Hypertension.

[34]  V. Campese,et al.  Renal afferent denervation prevents hypertension in rats with chronic renal failure. , 1995, Hypertension.

[35]  R. A. Johnson,et al.  Effects of renal denervation on postprandial sodium excretion in experimental heart failure. , 1994, The American journal of physiology.

[36]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[37]  S. Oparil,et al.  Neuronal control of the kidney: contribution to hypertension. , 1992, Canadian journal of physiology and pharmacology.

[38]  G. Dibona,et al.  Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. , 1991, The American journal of physiology.

[39]  E. Zambraski,et al.  Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. , 1990, American journal of hypertension.

[40]  T. Hedner,et al.  Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure. , 1989, Acta physiologica Scandinavica.

[41]  V. Kon Neural control of renal circulation. , 1989, Mineral and electrolyte metabolism.

[42]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[43]  J. López-Novoa,et al.  Effect of chemical sympathectomy on renal hydroelectrolytic handling in dogs with chronic caval constriction. , 1986, Clinical physiology and biochemistry.

[44]  G. Jennings,et al.  Mechanism of elevated plasma noradrenaline in the course of essential hypertension. , 1986, Journal of cardiovascular pharmacology.

[45]  J. L. le Noble,et al.  Pharmacological evidence for rapid destruction of efferent renal nerves in rats by intrarenal infusion of 6-hydroxydopamine. , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[46]  R. Katholi Renal nerves and hypertension: an update. , 1985, Federation proceedings.

[47]  M. Brody,et al.  Selective efferent chemical sympathectomy of rat kidneys. , 1985, The American journal of physiology.

[48]  R. A. Norman,et al.  Role of the renal nerves in one-kidney, one clip hypertension in rats. , 1984, Hypertension.

[49]  J. O. Davis,et al.  Pathogenesis of one-kidney, one-clip hypertension in rats after renal denervation. , 1984, The American journal of physiology.

[50]  S. Oparil,et al.  Importance of the Renal Nerves in Established Two‐Kidney, One Clip Goldblatt Hypertension , 1982, Hypertension.

[51]  D. Bichet,et al.  Renal intracortical blood flow and renin secretion after denervation by 6-hydroxydopamine. , 1982, Canadian journal of physiology and pharmacology.

[52]  S. Oparil,et al.  Role of the Renal Nerves in the Pathogenesis of One‐Kidney Renal Hypertension in the Rat , 1981, Hypertension.

[53]  L. Barajas Innervation of the renal cortex. , 1978, Federation proceedings.

[54]  A. Zanchetti Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. , 1977, Circulation.

[55]  C. W. Gottschalk,et al.  Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. , 1976, The Journal of clinical investigation.

[56]  C. Swartz,et al.  Blood Pressure Regulation in End‐Stage Renal Disease and Anephric Man , 1975, Circulation research.

[57]  R. Kerber,et al.  Effect of Alterations of Arterial Blood Pressure and Heart Rate on Segmental Dyskinesis during Acute Myocardial Ischemia and following Coronary Reperfusion , 1975, Circulation research.

[58]  H. Harris,et al.  The Rat , 1958, Nature.

[59]  J. Thompson,et al.  Splanchnicectomy for essential hypertension; results in 1,266 cases. , 1953, Journal of the American Medical Association.

[60]  W. Cooke,et al.  Sympathectomy in the treatment of hypertension; review of 122 cases. , 1953, Lancet.